Max Keller

1.4k citations

73 papers · 984 indexed · h-index 19

Impact in

Cellular and Molecular Neuroscience top 5%
- Neuropeptides and Animal Physiology
Molecular Biology top 10%
- Receptor Mechanisms and Signaling
- Chemical Synthesis and Analysis
- Pharmacological Receptor Mechanisms and Effects

Papers in ⓘ

Molecular Biology 55
- Receptor Mechanisms and Signaling 43
- Chemical Synthesis and Analysis 26
- Pharmacological Receptor Mechanisms and Effects 6
Cellular and Molecular Neuroscience 45
- Neuropeptides and Animal Physiology 39

Co-authors: Günther Bernhardt (33 shared papers)Armin Buschauer (26 shared papers)Burkhard König (6 shared papers)David Wifling (8 shared papers)Peter Gmeiner (10 shared papers)Lisa Schindler (9 shared papers)Nikola Pluym (4 shared papers)Harald Hübner (8 shared papers)
Journals: Journal of Medicinal Chemistry (15 papers)Bioorganic & Medicinal Chemistry (6 papers)ACS Medicinal Chemistry Letters (5 papers)ChemMedChem (4 papers)Scientific Reports (3 papers)
Partner nations: Germany Estonia United Kingdom

In The Last Decade

Max Keller

72 papers receiving 971 citations

Peers

Countries citing papers authored by Max Keller

Since Specialization

Citations

This map shows the geographic impact of Max Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Keller more than expected).

Fields of papers citing papers by Max Keller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Keller. The network helps show where Max Keller may publish in the future.

Co-authors

The 25 scholars most cited alongside Max Keller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Max Keller Line = papers co-authored together Max Keller links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Acylguanidines as Bioisosteres of Guanidines:N^G-Acylated Imidazolylpropylguanidines, a New Class of Histamine H₂Receptor Agonists Journal of Medicinal Chemistry ·Prasanta Ghorai, Anja Kraus, Max Keller, Carsten Götte, Patrick Igel, Erich Schneider, David Schnell, Günther Bernhardt, Stefan Dove, Manfred Zabel, Sigurd Elz, Roland Seifert, Armin Buschauer	2008	63
2	Synthesis and Characterization of the First Fluorescent Nonpeptide NPY Y₁ Receptor Antagonist ChemBioChem ·Erich Schneider, Max Keller, Albert Brennauer, Bianca K. Hoefelschweiger, Dietmar Gross, Otto S. Wolfbeis, Günther Bernhardt, Armin Buschauer	2007	46
3	G protein-coupled receptors function as logic gates for nanoparticle binding and cell uptake Proceedings of the National Academy of Sciences ·Wolfgang Hild, Klaus Pollinger, Andrea Caporale, Chiara Cabrele, Max Keller, Nikola Pluym, Armin Buschauer, Reinhard Rachel, Jörg Teßmar, Miriam Breunig, Achim Goepferich	2010	43
4	Initial Characterization of Transgenic Mice Overexpressing Human Histamine H2 Receptors Journal of Pharmacology and Experimental Therapeutics ·Ulrich Gergs, G. Bernhardt, Igor Buchwalow, H. Edler, Janine Fröba, Max Keller, Uwe Kirchhefer, Felix C. Kohler, N. Mißlinger, Hartmut Wache, Joachim Neumann	2019	42
5	Guanidine−Acylguanidine Bioisosteric Approach in the Design of Radioligands: Synthesis of a Tritium-LabeledN^G-Propionylargininamide ([³H]-UR-MK114) as a Highly Potent and Selective Neuropeptide Y Y₁Receptor Antagonist Journal of Medicinal Chemistry ·Max Keller, Nathalie Pop, Christoph Hutzler, Annette G. Beck‐Sickinger, Günther Bernhardt, Armin Buschauer	2008	42
6	Receptor-specific recognition of NPY peptides revealed by structures of NPY receptors Science Advances ·Tingting Tang, Qiuxiang Tan, Shuo Han, Anne Diemar, Kristin Löbner, Hongyu Wang, Corinna Schüß, Victoria Behr, Karin Mörl, Mu Wang, Xiaojing Chu, Cuiying Yi, Max Keller, Jacob Kofoed, Steffen Reedtz‐Runge, Anette Kaiser, Annette G. Beck‐Sickinger, Qiang Zhao, Beili Wu	2022	34
7	Mimicking of Arginine by FunctionalizedN^ω-Carbamoylated Arginine As a New Broadly Applicable Approach to Labeled Bioactive Peptides: High Affinity Angiotensin, Neuropeptide Y, Neuropeptide FF, and Neurotensin Receptor Ligands As Examples Journal of Medicinal Chemistry ·Max Keller, Kilian Kuhn, Jürgen Einsiedel, Harald Hübner, Sabrina Biselli, Catherine Mollereau, David Wifling, Jaroslava Svobodová, Günther Bernhardt, Chiara Cabrele, Patrick Vanderheyden, Peter Gmeiner, Armin Buschauer	2016	34
8	Red-fluorescent argininamide-type NPY Y1 receptor antagonists as pharmacological tools Bioorganic & Medicinal Chemistry ·Max Keller, Daniela Erdmann, Nathalie Pop, Nikola Pluym, Shangjun Teng, Günther Bernhardt, Armin Buschauer	2011	31
9	NG-Acyl-argininamides as NPY Y1 receptor antagonists: Influence of structurally diverse acyl substituents on stability and affinity Bioorganic & Medicinal Chemistry ·Stefan Weiß, Max Keller, Günther Bernhardt, Armin Buschauer, Burkhard König	2010	29
10	The Neuropeptide Y Y1 Receptor: A Diagnostic Marker? Expression in MCF-7 Breast Cancer Cells Is Down-Regulated by Antiestrogens In Vitro and in Xenografts PLoS ONE ·Martin Memminger, Max Keller, Miroslaw Lopuch, Nathalie Pop, Günther Bernhardt, Erwin von Angerer, Armin Buschauer	2012	24
11	High Affinity Agonists of the Neuropeptide Y (NPY) Y₄ Receptor Derived from the C-Terminal Pentapeptide of Human Pancreatic Polypeptide (hPP): Synthesis, Stereochemical Discrimination, and Radiolabeling Journal of Medicinal Chemistry ·Kilian Kuhn, Thomas Ertl, Stefanie Dukorn, Max Keller, Günther Bernhardt, Oliver Reiser, Armin Buschauer	2016	24
12	Dimeric carbamoylguanidine-type histamine H2 receptor ligands: A new class of potent and selective agonists Bioorganic & Medicinal Chemistry ·Nicole Kagermeier, Kristin Werner, Max Keller, Paul Baumeister, Günther Bernhardt, Roland Seifert, Armin Buschauer	2015	23
13	Conformations, Conformational Preferences, and Conformational Exchange of N′-Substituted N-Acylguanidines: Intermolecular Interactions Hold the Key Journal of the American Chemical Society ·Roland Kleinmaier, Max Keller, Patrick Igel, Armin Buschauer, Ruth M. Gschwind	2010	23
14	Highly Potent, Stable, and Selective Dimeric Hetarylpropylguanidine-Type Histamine H₂ Receptor Agonists ACS Omega ·Steffen Pockes, David Wifling, Max Keller, Armin Buschauer, Sigurd Elz	2018	23
15	Modular synthesis of non-peptidic bivalent NPY Y1 receptor antagonists Bioorganic & Medicinal Chemistry ·Stefan Weiß, Max Keller, Günther Bernhardt, Armin Buschauer, Burkhard König	2008	22
16	Radiolabeled Dibenzodiazepinone-Type Antagonists Give Evidence of Dualsteric Binding at the M₂ Muscarinic Acetylcholine Receptor Journal of Medicinal Chemistry ·Andrea Pegoli, Xueke She, David Wifling, Harald Hübner, Günther Bernhardt, Peter Gmeiner, Max Keller	2017	20
17	Fluorescence Labeling of Neurotensin(8–13) via Arginine Residues Gives Molecular Tools with High Receptor Affinity ACS Medicinal Chemistry Letters ·Max Keller, Shahani A. Mahuroof, Vivyanne Hong Yee, Jessica Carpenter, Lisa Schindler, Timo Littmann, Andrea Pegoli, Harald Hübner, Günther Bernhardt, Peter Gmeiner, Nicholas D. Holliday	2019	20
18	N^ω-Carbamoylation of the Argininamide Moiety: An Avenue to Insurmountable NPY Y₁ Receptor Antagonists and a Radiolabeled Selective High-Affinity Molecular Tool ([³H]UR-MK299) with Extended Residence Time Journal of Medicinal Chemistry ·Max Keller, Stefan Weiß, Christoph Hutzler, Kilian Kuhn, Catherine Mollereau, Stefanie Dukorn, Lisa Schindler, Günther Bernhardt, Burkhard König, Armin Buschauer	2015	19
19	Application of the Guanidine–Acylguanidine Bioisosteric Approach to Argininamide‐Type NPY Y₂ Receptor Antagonists ChemMedChem ·Nikola Pluym, Albert Brennauer, Max Keller, Ralf Ziemek, Nathalie Pop, Günther Bernhardt, Armin Buschauer	2011	18
20	Heterodimerization of Dibenzodiazepinone-Type Muscarinic Acetylcholine Receptor Ligands Leads to Increased M₂R Affinity and Selectivity ACS Omega ·Xueke She, Andrea Pegoli, Judith Mayr, Harald Hübner, Günther Bernhardt, Peter Gmeiner, Max Keller	2017	17

About Max Keller

Max Keller is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Oncology, Materials Chemistry and Radiology, Nuclear Medicine and Imaging, having authored 73 papers that have together received 984 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (43 papers), Neuropeptides and Animal Physiology (39 papers), Chemical Synthesis and Analysis (26 papers), Peptidase Inhibition and Analysis (7 papers), Pharmacological Receptor Mechanisms and Effects (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Mast cells and histamine (4 papers) and Neuroendocrine Tumor Research Advances (4 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (485 citations), Molecular Biology (737 citations), Biophysics (33 citations), Immunology (108 citations) and Organic Chemistry (134 citations). Max Keller has collaborated with scholars based in Germany, Estonia and United Kingdom. Frequent co-authors include Günther Bernhardt, Armin Buschauer, Burkhard König, David Wifling, Peter Gmeiner, Lisa Schindler, Nikola Pluym, Harald Hübner, Erich Schneider and Annette G. Beck‐Sickinger. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, ACS Medicinal Chemistry Letters, ChemMedChem and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact